BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 854478)

  • 1. The effect of a low-protein diet on some pharmacokinetic parameters of hexobarbital in the rat.
    Czyzewska-Szafran H; Nowak K; Wutkiewicz M
    Pol J Pharmacol Pharm; 1977; 29(1):1-6. PubMed ID: 854478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of low protein diet on sleeping time and on the metabolism of hexobarbital in rats.
    Czyzewska-Szafran H; Lastowska K; Obojska K; Wutkiewicz M
    Pol J Pharmacol Pharm; 1975; 27(6):625-30. PubMed ID: 1208235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective metabolism of the enantiomers of hexobarbital.
    Furner RL; McCarthy JS; Stitzel RE; Anders MW
    J Pharmacol Exp Ther; 1969 Oct; 169(2):153-8. PubMed ID: 5824599
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors affecting the metabolism and response to hexobarbital.
    Furner RL; Gram TE; Stitzel RE
    Pharmacology; 1969; 2(3):181-9. PubMed ID: 5346144
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of thiamine consumption on liver microsomal drug-metabolizing pathways.
    Grosse W; Wade AE
    J Pharmacol Exp Ther; 1971 Mar; 176(3):758-65. PubMed ID: 4398746
    [No Abstract]   [Full Text] [Related]  

  • 6. [Circadian fluctuations of pharmacokinetic parameters after oral administration of hexobarbital (author's transl)].
    Altmayer P; Groterath E; Lücker PW; Mayer D; von Mayersbach H; Rindt W; Wetzelsberger K
    Arzneimittelforschung; 1979; 29(9):1422-8. PubMed ID: 583253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic fate of hexobarbital in the rat.
    Holcomb RR; Gerber N; Bush MT
    J Pharmacol Exp Ther; 1974 Jan; 188(1):15-26. PubMed ID: 4809266
    [No Abstract]   [Full Text] [Related]  

  • 8. [The relationship between the inhibition of protein synthesis and the induction of microsomal enzymes by barbital (author's transl)].
    Kröner H
    Z Klin Chem Klin Biochem; 1973 Jan; 11(1):20-3. PubMed ID: 4804137
    [No Abstract]   [Full Text] [Related]  

  • 9. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ethanol on rates of elimination and metabolism of zoxazolamine, hexobarbital and warfarin sodium in the rat.
    Mallov S; Baesl TJ
    Biochem Pharmacol; 1972 Jun; 21(12):1667-78. PubMed ID: 4649128
    [No Abstract]   [Full Text] [Related]  

  • 11. [Toxicity, narcotic effect, blood level after awakening, elimination from the blood and biotransformation of hexobarbital in rats of different ages after induction with barbital and carbon tetrachloride poisoning].
    Klinger W
    Arch Int Pharmacodyn Ther; 1970 Mar; 184(1):5-18. PubMed ID: 5448769
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of cyproterone acetate pretreatment on the in vitro metabolism of aniline, hexobarbital and 3 H-digitoxigenin.
    Talcott RE; Stohs SJ
    J Pharmacol Exp Ther; 1973 Feb; 184(2):419-23. PubMed ID: 4688178
    [No Abstract]   [Full Text] [Related]  

  • 13. Disulfiram impairment of drug metabolism by rat liver microsomes.
    Stripp B; Greene FE; Gillette JR
    J Pharmacol Exp Ther; 1969 Dec; 170(2):347-54. PubMed ID: 4391007
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetic differences in the microsomal metabolism of the isomers of hexobarbital.
    McCarthy JS; Stitzel RE
    J Pharmacol Exp Ther; 1971 Mar; 176(3):772-8. PubMed ID: 5111462
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of hexobarbital metabolism by pyridyl derivatives.
    Varga F; Hankovszky OH; Hideg K; Fischer E; Szily T
    Acta Physiol Acad Sci Hung; 1973; 44(3-4):235-45. PubMed ID: 4807136
    [No Abstract]   [Full Text] [Related]  

  • 16. Diphenylhydantoin effect on neonatal and adult rat hepatic drug metabolism.
    Eling TE; Harbison RD; Becker BA; Fouts JR
    J Pharmacol Exp Ther; 1970 Jan; 171(1):127-34. PubMed ID: 5410930
    [No Abstract]   [Full Text] [Related]  

  • 17. Diphenylhydantoin effects on hexobarbital and aniline biotransformation in male rats: differences between in vitro and in vivo observations.
    Gut I; Becker BA
    Toxicol Appl Pharmacol; 1975 Nov; 34(2):253-8. PubMed ID: 1209623
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of perinatal low protein diets on the ontogeny of select hepatic cytochrome p450 enzymes and cytochrome p450 reductase in the rat.
    Cherala G; Shapiro BH; D'mello AP
    Drug Metab Dispos; 2007 Jul; 35(7):1057-63. PubMed ID: 17392395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of hexobarbital and aniline to cytochrome P-450 of liver microsomes from control and phenobarbital-treated rats of different ages.
    Müller D; Klinger W
    Acta Biol Med Ger; 1976; 35(5):627-33. PubMed ID: 983613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thiamine and dietary linoleate levels on hepatic drug metabolism in the male rat.
    Wade AE; Caster WO; Greene FE; Meadows JS
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):466-73. PubMed ID: 5403612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.